Skip to main content
Thorax logoLink to Thorax
. 2004 Apr;59(4):279–285. doi: 10.1136/thx.2003.010405

Outbreak of isoniazid resistant tuberculosis in north London

M Ruddy 1, A Davies 1, M Yates 1, S Yates 1, S Balasegaram 1, Y Drabu 1, B Patel 1, S Lozewicz 1, S Sen 1, M Bahl 1, E James 1, M Lipman 1, G Duckworth 1, J Watson 1, M Piper 1, F Drobniewski 1, H Maguire 1
PMCID: PMC1763803  PMID: 15047945

Abstract

Background: A description is given of a major outbreak of isoniazid monoresistant tuberculosis (TB) chiefly in north London, including prisons. The earliest case was diagnosed in 1995 with most cases appearing after 1999.

Methods: Confirmation of a local cluster of cases was confirmed by restriction fragment length polymorphism (RFLP IS6110) typing or "rapid epidemiological typing" (RAPET). Further cases were found by retrospective analysis of existing databases, prospective screening of new isolates, and targeted epidemiological case detection including questionnaire analysis.

Results: By the end of 2001, 70 confirmed cases in London had been linked with a further 13 clinical cases in contacts and nine epidemiologically linked cases outside London. The epidemic curve suggests that the peak of the outbreak has not yet been reached. Cases in the outbreak largely belong to a social group of young adults of mixed ethnic backgrounds including several individuals from professional/business backgrounds. Compared with other cases of TB reported to the enhanced surveillance scheme in London during 1999–2001, the cases are more likely to be of white (26/70 (37%) v 1308/7666 (17%)) or black Caribbean ethnicity (17/70 (24%) v 312/7666 (4%)), born in the UK (41/70 (59%) v 1335/7666 (17%)), and male (52/70 (74%) v 4195/7666 (55%)). Drug misuse and/or prison detention are factors common to many cases.

Conclusions: The investigation of the outbreak revealed significant problems on an individual patient and population based level including difficulties with contact tracing, compliance, and the risk of developing multidrug resistance. This incident has demonstrated the value of molecular strain typing in investigating an extensive outbreak of TB. This is the first documented outbreak involving a UK prison.

Full Text

The Full Text of this article is available as a PDF (462.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNETT M., BUSBY S. R., MITCHISON D. A. Tubercle bacilli resistant to isoniazid: virulence and response to treatment with isoniazid in guinea-pigs and mice. Br J Exp Pathol. 1953 Oct;34(5):568–581. [PMC free article] [PubMed] [Google Scholar]
  2. Coninx R., Mathieu C., Debacker M., Mirzoev F., Ismaelov A., de Haller R., Meddings D. R. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet. 1999 Mar 20;353(9157):969–973. doi: 10.1016/s0140-6736(98)08341-x. [DOI] [PubMed] [Google Scholar]
  3. Drobniewski F. A. Diagnosing multidrug resistant tuberculosis in Britain. Clinical suspicion should drive rapid diagnosis. BMJ. 1998 Nov 7;317(7168):1263–1264. doi: 10.1136/bmj.317.7168.1263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Drobniewski F. Tuberculosis in prisons--forgotten plague. Lancet. 1995 Oct 7;346(8980):948–949. doi: 10.1016/s0140-6736(95)91562-1. [DOI] [PubMed] [Google Scholar]
  5. Fujiwara P. I., Larkin C., Frieden T. R. Directly observed therapy in New York City. History, implementation, results, and challenges. Clin Chest Med. 1997 Mar;18(1):135–148. doi: 10.1016/s0272-5231(05)70363-4. [DOI] [PubMed] [Google Scholar]
  6. MIDDLEBROOK G., COHN M. L., SCHAEFER W. B. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc. 1954 Nov;70(5):852–872. doi: 10.1164/art.1954.70.5.852. [DOI] [PubMed] [Google Scholar]
  7. Maguire H., Dale J. W., McHugh T. D., Butcher P. D., Gillespie S. H., Costetsos A., Al-Ghusein H., Holland R., Dickens A., Marston L. Molecular epidemiology of tuberculosis in London 1995-7 showing low rate of active transmission. Thorax. 2002 Jul;57(7):617–622. doi: 10.1136/thorax.57.7.617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Pilote L., Tulsky J. P., Zolopa A. R., Hahn J. A., Schecter G. F., Moss A. R. Tuberculosis prophylaxis in the homeless. A trial to improve adherence to referral. Arch Intern Med. 1996 Jan 22;156(2):161–165. [PubMed] [Google Scholar]
  9. Ruddy M., McHugh T. D., Dale J. W., Banerjee D., Maguire H., Wilson P., Drobniewski F., Butcher P., Gillespie S. H. Estimation of the rate of unrecognized cross-contamination with mycobacterium tuberculosis in London microbiology laboratories. J Clin Microbiol. 2002 Nov;40(11):4100–4104. doi: 10.1128/JCM.40.11.4100-4104.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Valway S. E., Sanchez M. P., Shinnick T. F., Orme I., Agerton T., Hoy D., Jones J. S., Westmoreland H., Onorato I. M. An outbreak involving extensive transmission of a virulent strain of Mycobacterium tuberculosis. N Engl J Med. 1998 Mar 5;338(10):633–639. doi: 10.1056/NEJM199803053381001. [DOI] [PubMed] [Google Scholar]
  11. Wright M., Main J., Thomas H. C. Drug-resistant viral hepatitis. J Infect. 2000 Jul;41(1):1–4. doi: 10.1053/jinf.2000.0658. [DOI] [PubMed] [Google Scholar]
  12. Yates Malcolm D., Drobniewski Francis A., Wilson Stuart M. Evaluation of a rapid PCR-based epidemiological typing method for routine studies of Mycobacterium tuberculosis. J Clin Microbiol. 2002 Feb;40(2):712–714. doi: 10.1128/JCM.40.2.712-714.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. van Embden J. D., Cave M. D., Crawford J. T., Dale J. W., Eisenach K. D., Gicquel B., Hermans P., Martin C., McAdam R., Shinnick T. M. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol. 1993 Feb;31(2):406–409. doi: 10.1128/jcm.31.2.406-409.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES